Literature DB >> 17766043

Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis.

Jessica L Lynch1, Nathan J Gallus, Marna E Ericson, Alvin J Beitz.   

Abstract

Although pain was previously not considered an important element of multiple sclerosis (MS), recent evidence indicates that over 50% of MS patients suffer from chronic pain. In the present study, we utilized the Theiler's murine encephalomyelitis virus (TMEV) model of MS to examine whether changes in nociception occur during disease progression and to investigate whether sex influences the development of nociception or disease-associated neurological symptoms. Using the rotarod assay, TMEV infected male mice displayed increased neurological deficits when compared to TMEV infected female mice, which mimics what is observed in human MS. While both male and female TMEV infected mice exhibited thermal hyperalgesia and mechanical allodynia, female mice developed mechanical allodynia at a faster rate and displayed significantly more mechanical allodynia than male mice. Since neuropathic symptoms have been described in MS patients, we quantified sensory nerve fibers in the epidermis of TMEV-infected and non-infected mice to determine if there were alterations in epidermal nerve density. There was a significantly higher density of PGP9.5 and CGRP-immunoreactive axons in the epidermis of TMEV-infected mice versus controls. Collectively these results indicate that the TMEV model is well suited to study the mechanisms of MS-induced nociception and suggest that alterations in peripheral nerve innervation may contribute to MS pain.

Entities:  

Mesh:

Year:  2007        PMID: 17766043      PMCID: PMC2673489          DOI: 10.1016/j.pain.2007.07.007

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  78 in total

1.  ELECTROMYOGRAPHIC STUDY ON SO-CALLED MONONEURITIS.

Authors:  H C HOPF
Journal:  Arch Neurol       Date:  1963-09

Review 2.  Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.

Authors:  M Rodriguez; E Oleszak; J Leibowitz
Journal:  Crit Rev Immunol       Date:  1987       Impact factor: 2.214

Review 3.  Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis.

Authors:  Subramaniam Sriram; Israel Steiner
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

4.  Peripheral nerve abnormality in multiple sclerosis.

Authors:  M Pollock; C Calder; S Allpress
Journal:  Ann Neurol       Date:  1977-07       Impact factor: 10.422

5.  Prevalence of multiple sclerosis in the L'Aquila district, central Italy.

Authors:  R Totaro; C Marini; A Cialfi; M Giunta; A Carolei
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

6.  More severe neurologic deficits in SJL/J male than female mice following Theiler's virus-induced CNS demyelination.

Authors:  Jeremy Alley; Sergey Khasabov; Don Simone; Alvin Beitz; Moses Rodriguez; M Kariuki Njenga
Journal:  Exp Neurol       Date:  2003-03       Impact factor: 5.330

7.  Free 3-nitrotyrosine causes striatal neurodegeneration in vivo.

Authors:  M J Mihm; B L Schanbacher; B L Wallace; L J Wallace; N J Uretsky; J A Bauer
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 8.  Central hypersensitivity in chronic pain: mechanisms and clinical implications.

Authors:  Michele Curatolo; Lars Arendt-Nielsen; Steen Petersen-Felix
Journal:  Phys Med Rehabil Clin N Am       Date:  2006-05       Impact factor: 1.784

9.  BDNF overexpression induces differential increases among subsets of sympathetic innervation in murine back skin.

Authors:  V A Botchkarev; N V Botchkareva; M Lommatzsch; E M Peters; G R Lewin; A Subramaniam; A Braun; H Renz; R Paus
Journal:  Eur J Neurosci       Date:  1998-10       Impact factor: 3.386

10.  Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists.

Authors:  T Kümpfel; L A Hoffmann; W Pöllmann; P Rieckmann; U K Zettl; R Kühnbach; G D Borasio; R Voltz
Journal:  Palliat Med       Date:  2007-03       Impact factor: 4.762

View more
  17 in total

1.  A bio-mimetic approach to DNA photoprotection.

Authors:  Abbas Raza; Marna E Ericson; Jaime S Nugent; Christine D Dreis; Robert Vince
Journal:  J Invest Dermatol       Date:  2013-08-12       Impact factor: 8.551

2.  microRNA-219 Reduces Viral Load and Pathologic Changes in Theiler's Virus-Induced Demyelinating Disease.

Authors:  Ana Lis Moyano; Jeffrey Steplowski; Haibo Wang; Kyung-No Son; Diana I Rapolti; Jeffrey Marshall; Vince Elackattu; Michael S Marshall; Amy K Hebert; Cory R Reiter; Viviana Ulloa; Katarzyna C Pituch; Maria I Givogri; Q Richard Lu; Howard L Lipton; Ernesto R Bongarzone
Journal:  Mol Ther       Date:  2018-01-17       Impact factor: 11.454

Review 3.  Management of pain in multiple sclerosis: a pharmacological approach.

Authors:  Claudio Solaro; Michele Messmer Uccelli
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

4.  Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

Authors:  Divyanshoo R Kohli; Yunfang Li; Sergey G Khasabov; Pankaj Gupta; Lois J Kehl; Marna E Ericson; Julia Nguyen; Vinita Gupta; Robert P Hebbel; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2010-03-19       Impact factor: 22.113

Review 5.  Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain.

Authors:  Paola Sacerdote; Silvia Franchi; Sarah Moretti; Mara Castelli; Patrizia Procacci; Valerio Magnaghi; Alberto E Panerai
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-16       Impact factor: 4.147

6.  Elevation of tumor necrosis factor α in dorsal root ganglia and spinal cord is associated with neuroimmune modulation of pain in an animal model of multiple sclerosis.

Authors:  F Begum; W Zhu; C Cortes; B MacNeil; M Namaka
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-14       Impact factor: 4.147

Review 7.  Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.

Authors:  Elizabeth J Rahn; Andrea G Hohmann
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

8.  Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.

Authors:  Peter M Grace; Lisa C Loram; John P Christianson; Keith A Strand; Johanna G Flyer-Adams; Kathryn R Penzkover; John R Forsayeth; Anne-Marie van Dam; Melissa J Mahoney; Steven F Maier; Raymond A Chavez; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2016-05-14       Impact factor: 7.217

9.  Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis.

Authors:  Jessica L Lynch; Jeremy F Alley; Lori Wellman; Alvin J Beitz
Journal:  Brain Res       Date:  2007-11-28       Impact factor: 3.252

10.  Social disruption alters pain and cognition in an animal model of multiple sclerosis.

Authors:  H R Linsenbardt; J L Cook; E E Young; E G Vichaya; C R Young; N M Reusser; R Storts; C J Welsh; M W Meagher
Journal:  J Neuroimmunol       Date:  2015-09-12       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.